Universität Wien

323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2024S)

(2 Courses)

5.00 ECTS (1.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung
Moodle

An/Abmeldung

Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").

Details

Sprache: Englisch

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

Case study schedule is in progress. Please see the Moodle platform for updates and instructions.
Enrollment in the Master in Preclinical Drug Discovery program and successful completion of MPS1 are required to enroll in this course.

First day of the MPS7 Case Studies: Wednesday, 10 April 8:00 - 9:00 (Web-based-Zoom) - All participants

Participants will be assigned to a Case Study. Information about the Case Studies can be found on Moodle.

Case Study 1 (Schedule for Case Study 1 Participants):
Thursday 11.04.2024 14:00 - 16:00 (Web-Based-Zoom)
Tuesday 14.05.2024 14:00 - 16:00 (Web-Based-Zoom)
Monday 18.06.2024 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II 2D313

Case Study 2 (Schedule for Case Study 2 Participants):
Thursday 18.04.2024 8:30 - 10:30 (Web-Based-Zoom)
Tuesday 03.05.2024 8:30 - 10:30 (Web-Based-Zoom)
Monday 10.06.2024 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II 2D313

Case Study 3 (Schedule for Case Study 3 Participants) - Schedule in progress

  • Dienstag 04.06. 14:00 - 16:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Montag 10.06. 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Students must attend all sessions and actively participate in the discussions, complete and submit all of the assignments on time. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal that is due before the last day of class and to actively contribute to research and team activities outside of the lecture periods towards completing assignments and fulfilling the requirements of the course. Students are expected to incorporate and make use of knowledge gained in MPS1-MPS6 of the Master in Drug Discovery program.

Mindestanforderungen und Beurteilungsmaßstab

Enrollment in the Master of Drug Discovery and Development program and successful completion of MPS1 in the Master of Drug Discovery and Development program are required to attend this course. Course attendance to all sessions, completion of all assignments including revisions from feedback sessions to be submitted to instructors for evaluation on time and the final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors, are all minimum requirements for the course.

Prüfungsstoff

Team presentation of the finalized project proposal (each team member must present)
Submission of the finalized research proposal and presentation slide deck.

Literatur

To be given in class

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Mi 20.03.2024 10:47